40 results
Page 2 of 2
8-K
EX-99.1
9fivlu unn
11 Jan 21
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
ny3uhpgk
20 Nov 20
Stoke Therapeutics Announces Pricing of $97.5 Million Public Offering
4:08pm
8-K
EX-99.1
2t8zyt2qa
12 Nov 20
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
7:40am
8-K
EX-99.1
euhqb q4rmvn
17 Aug 20
Stoke Therapeutics Announces Appointment of Garry E. Menzel, Ph.D., to its Board of Directors
7:46am
8-K
EX-99.1
v5dg0i4n2lk 0n90hw7
10 Aug 20
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
7:07am
8-K
EX-99.1
4i9ppp4w ym330ow9
9 Jul 20
Regulation FD Disclosure
6:06am
8-K
r3dp t9phe5aua87k
9 Jul 20
Regulation FD Disclosure
6:06am
8-K
EX-99.1
wzzykdi1hw1m5wk3gk0
15 May 20
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
7:05am
8-K
EX-99.1
j8tp ob8k6o
12 May 20
Regulation FD Disclosure
10:50am
10-K
667qqllcm tv24rqobm7
23 Mar 20
Annual report
4:02pm
8-K
EX-99.1
9jmhgdl
23 Mar 20
STOKE THERAPEUTICS Reports FULL YEAR 2019 financial results and provides business updateS
8:00am
424B4
jvxv3g5jy4m36b2hj
19 Jun 19
Prospectus supplement with pricing info
4:16pm
S-1/A
a2olyyb
7 Jun 19
IPO registration (amended)
6:08am
S-1
q90ipw9 2ui83nte4c
23 May 19
IPO registration
4:02pm
DRS/A
dasfx
30 Apr 19
Draft registration statement (amended)
12:00am
DRS
63eupeum552w spi
26 Mar 19
Draft registration statement
12:00am